SIAPS’ role to control malaria was recently featured in Health & Humanitarian: The Supply Chain Review. Between 2000 and 2015, malaria case incidences declined by 41% and mortality rates by 62%. However, approximately 212 million people were infected and 429,000 people died in 2015, with the majority being children under the age of 5 in […]
Archive | MaliRSS feed for this section
SIAPS has received funding from the US President’s Malaria Initiative (PMI) to work in eight countries—Angola, Burundi, Democratic Republic of the Congo (DRC), Ethiopia, Kenya, Guinea, Mali, and South Sudan—to strengthen pharmaceutical systems for improved malaria control. This report synthesizes the pharmaceutical systems strengthening efforts of SIAPS and documents how the approach was used to support efforts to control malaria.
Defeating malaria through pharmaceutical systems strengthening: A review of SIAPS’s activities in eight countries
SIAPS recently published the results of its activities in eight countries (Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Kenya, Guinea, Mali, and South Sudan) to control malaria. This report summarizes systems strengthening interventions that support the prevention and treatment of malaria. With funding from the US President’s Malaria Initiative (PMI) and based […]
To better coordinate activities undertaken by all interested stakeholders to control the Ebola outbreak, the Malian government enacted Decision N° 2014-0850/PM-RM of November 14, 2014, resulting in the development of a contingency plan and the establishment of an Emergency Operations Center (EOC). A quantification exercise was conducted with technical assistance and financing from the SIAPS Program for the preparation of consensus-based forecasts, with input from interested stakeholders. This process will facilitate efforts to raise and secure funding for the procurement of needed commodities for the control of Ebola.
This edition of the end-use verification (EUV) survey was conducted from August 9-31, 2016 under the leadership of the National Malaria Control Program (NMCP) in the regions of Southern and Central Mali. The survey aims to help improve the availability, management, and use of pharmaceuticals and other malaria commodities at public and quasi-public health facilities in Mali.
Rapport de quantification des produits de la santé reproductive, maternelle, néonatale, et infantile pour la période de janvier 2016 à décembre 2020
L’accès à des médicaments appropriés est vital pour parvenir aux objectifs mondiaux en matière de santé, en particulier les produits destinés pour la santé de la femme et de l’enfant. Un élément majeur de l’accès est de garantir la disponibilité des produits. Pour cela, la quantification des besoins est indispensable. La présente activité a apporté un soutien au Ministère de la Santé et de l’Hygiène Publique (MSHP) pour la quantification des besoins en médicaments pour la santé reproductive, maternelle, néonatale, et infantile (SRMNI). C’est ainsi que la Direction de la Pharmacie et du Médicament (DPM), à travers l’appui technique et financier de SIAPS, a organisé un atelier de quantification des besoins de ces produits. Avec la participation de tous les principaux intervenants dans le but de produire des besoins prévisionnels, un plan d’approvisionnement pour la période de 2016 à 2020 était préparé.
Developing a CMS strategic plan can help align pharmaceutical supply chain objectives with overall public-sector health supply chain strategies. It can help ensure that health commodities are readily available to health facilities through an uninterrupted supply chain; minimize waste and losses; improve business and financial growth; and respond to changes in the supply chain, such as new technologies and emerging markets. In addition, advocating for and encouraging stakeholders to assess the medicine supply chain system can increase interest in generating additional technical, financial, and material resources for health care. Supply chain interventions can also contribute to improving rational medicine use and strengthening pharmaceutical regulation.
The main purpose of developing product codes for the PPM is to standardize and improve inventory management practices at the PPM, to provide input to the PPM’s product master list, and to integrate the list throughout the commodity information system. In addition, the codes will be used in the product catalogue for clients to order from.
Technical Approach to Developing a Strategic Plan to Strengthen the Central Medical Store: The Case of Pharmacie Populaire du Mali
This document describes the techniques and experiences of and lessons learned from developing a strategic plan for the Pharmacie Populaire du Mali (PPM). Technical assistance providers, managers of pharmaceutical supply chain organizations, and consultants can adapt this information to suit local contexts and needs and apply it to their own public health pharmaceutical supply chain strategic plans.
SIAPS employed a systematic and structured approach to support PPM in developing its first strategic plan, including defining the scope and refining the task of developing a strategic plan through consultation with key stakeholders; conducting a national supply chain situational analysis that included country context–political, environmental, social, legislative, economic, and ethical factors–identifying gaps between the organization’s mission and vision and the expectations of clients and stakeholders; prioritizing and developing strategic objectives; and action planning and budgeting.
The catastrophic Ebola epidemic that began in 2014 aggravated Sierra Leone’s already weak pharmaceutical supply system. The country’s pharmaceutical storage, handling, distribution, and waste disposal programs were in dire need of improvement. A “push system” of standardized medicine deliveries without reliable use data compromised inventory control and accurate forecasting, leading to frequent stock-outs or overstocks. Cost recovery also functioned poorly, potentially impacting future health care resources.
The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, implemented by Management Sciences for Health (MSH), received two years of funding in September 2015 from the US Agency for International Development (USAID) to provide technical assistance for rebuilding and strengthening the post-Ebola pharmaceuti-cal supply chain management system in Sierra Leone. SIAPS helped the country institute a continuous results monitoring and support system (CRMS) to assess baseline challenges in pharmaceutical management and regularly track and support improvement in key areas. The CRMS uses a series of indicators to track and monitor factors that influence medicine availability and disease case management. Developed in Ethiopia in 2009 to bolster malaria treatment, CRMS has proven valuable in tracking performance trends so that partners and stakeholders can come together to address service gaps.
Join us for our new webinar on Tuesday, October 24, at 12:00 pm EST to learn more about SIAPS’ approach […]
Despite being one of the most densely populated countries in the world, the overall health in Bangladesh has steadily improved […]
The Philippines has one of the highest TB burdens in the world—and 2.6% of its more than 286,000 new cases […]